Innospec Inc. (IOSP) Issues Earnings Results
Innospec Inc. (NASDAQ:IOSP) released its earnings results on Tuesday. The specialty chemicals company reported $1.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.08, Bloomberg Earnings reports. Innospec had a return on equity of 14.63% and a net margin of 8.24%.
Shares of Innospec (NASDAQ IOSP) traded down 2.37% during mid-day trading on Wednesday, hitting $61.90. The stock had a trading volume of 15,363 shares. The stock has a market capitalization of $1.49 billion, a P/E ratio of 18.99 and a beta of 1.15. Innospec has a 52 week low of $54.45 and a 52 week high of $74.75. The stock has a 50 day moving average of $64.23 and a 200-day moving average of $65.13.
Several analysts have recently weighed in on IOSP shares. Zacks Investment Research raised Innospec from a “hold” rating to a “strong-buy” rating and set a $73.00 price objective on the stock in a report on Tuesday, May 16th. ValuEngine lowered Innospec from a “buy” rating to a “hold” rating in a report on Monday. Finally, BidaskClub lowered Innospec from a “sell” rating to a “strong sell” rating in a report on Thursday, July 27th.
A number of large investors have recently modified their holdings of IOSP. SG Americas Securities LLC bought a new stake in shares of Innospec during the second quarter worth about $106,000. Ameritas Investment Partners Inc. bought a new stake in shares of Innospec during the first quarter worth about $132,000. Victory Capital Management Inc. increased its stake in shares of Innospec by 18.1% in the first quarter. Victory Capital Management Inc. now owns 2,311 shares of the specialty chemicals company’s stock worth $150,000 after buying an additional 354 shares in the last quarter. State of Alaska Department of Revenue increased its stake in shares of Innospec by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 2,660 shares of the specialty chemicals company’s stock worth $172,000 after buying an additional 70 shares in the last quarter. Finally, Stevens Capital Management LP bought a new stake in shares of Innospec during the first quarter worth about $240,000. 90.52% of the stock is currently owned by institutional investors and hedge funds.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with MarketBeat.com's FREE daily email newsletter.